Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall.

doi:10.1007/s10014-019-00356-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall.

Brain tumor pathology - 1 Jan 2020

Tan C L, Lian D W Q, Kuick C H, Chan Y H, Chang K T E

Abstract excerpt

Mitogen-activated protein kinase (MAPK) pathway plays a major role in pediatric low-grade gliomas (pLGGs). Immunohistochemistry with mutant-specific antibody, VE1, has appeared to be the most affordable and rapidly deployable method to identify tumors with aberrant MAPK signaling pathway, by highlighting tumor with BRAFV600E mutation. Nonetheless, positive staining cases but not associated with BRAFV600E mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Brain Neoplasms
Share to Gene Fusion
Share to Glioma

Source

Open in PubMed

Identifiers

PMID: 31820133
DOI: 10.1007/s10014-019-00356-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to MAP Kinase Signaling System

Share to Membrane Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Staining and Labeling